Selenium supplementation in thyroid associated ophthalmopathy: An update

International Journal of Ophthalmology

Volumn 7, Issue 2, 2014, Pages 365-375

  Dharmasena, Aruna ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

Graves'orbit opathy; Selenium; Selenoproteins; Thy roid associated ophthalmopathy

Indexed keywords

EID: 84899817693     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2014.02.31     Document Type: Article

References (135)

1. Weeks BS, Hanna MS, Cooperstein D. Dietary selenium and selenoprotein function. Med Sci Monit. 2012;l8(8):RAl27-132. [PMCfreearticle] [PubMed]
2. Przybylik-Mazurek E, Zagrodzki P, Kuzniarz-Rymarz S, Hubalewska-Dydejczyk A. Thyroid disorders-Assessments of trace elements, clinical, and laboratory parameters. Bil Trace El em Res. 20115141(1-3) 165-75. [PubMed]
3. Giinzler WA, Steffens GJ, Grossmann A, Kim SM, Otting F, Wendel A, Fhe L. The amino-Acid sequence of bovine glutathne peroxidase. Hoppe Seyler's Z Phys Chem. 1984;353:195-212. [PubMed]
4. Zinoni F, Birkmann A, Stadtman TC, Bock A. Nucleotide sequence and expressn of theselenocysteine-containin g poly peptide of form ate dehydrogenase (formate-hydrogen-lyase-1 inked) from Escherichia coli. Proc Natl AcadSci USA. l986;83(l3):4650-4654. [PMCfreearticle] [PubMed]
5. Bock A, Forch hammer K, Heider J, Baron C. Selenoprotein synthesis: an expansn of the genetic code. Trends Bichemical Sci. 1991;l6(l2):463-46y. [PubMed]
6. Schomburg L. Selenium, selenoproteins andthethyroidgland: interactions in health anddisease. Nat Rev Endocrii 2011;8(3):l6o-l7l. [PubMed]
7. Hardy G, Hardy I, Manzanares W. Selenium supplementation in the critically ill. Nutr Clin Pract. 2012527(1) 121-33 [PubMed]
8. Fhe L, Gunzler EA, Schock HH. Glutathne peroxidase: a selenoenzyme. FEBS Lett. 1973;32(l):l32-134. [PubMed]
9. Rotruck JT, Pope AL, Ganther H, Swanson A, Hafeman DG, Hoekstra WG. Selenium:b10chemical role as a component glutathne peroxidase. Science. 1973;179(4073):588-590. [PubMed]
10. FheL, Andreesen JR, Brigelius-Fhe R, Ma rinoM, Ursini F. Selenium, the element of the moon, in life and eart IUBMB Life. 200049(5):4ll-420. [PubMed]
11. Andreesen JR, Ljungdahl L. Formate dehydrogenase of Cstridium thermoaceticum: incorporation of selenium-75 and the effect of selenite, molybdate andtungstate on the enzyme. JBacter10l. 19735116(2) 1867-873. [PMCfree article] [PubMed]
12. Turner DC, Stadtman TC. Purification of protein components of thecstridial glycine reductase system and characterization of protein A as a selenoprotein. Arch Bichem Biphys. 1973;l54(l):366-38l. [PubMed]
13. Tayr D, Dal ton C, Hall A, Woodroofe MN, Gardiner PH. Recent devements in selenium research. Br J Bimed Sci 2009;66(2):107-ll6. [PubMed]
14. Kohrle J, Gartner R. Selenium andthyroid. Best Pract Res Clin Endocrinol Metab. 2009;23(6):8l5-827. [PubMed]
15. Bierl C, Voetsch B, Jin RC, Handy DE, scalzoJ. Determinants of human plasma glutathne peroxidase (GPx-3) expressn. JBil Chem. 2004;279(26):26839- 26845. [PubMed]
16. Rayman MP. Selenoproteins and human health: Insights from epidemgical data. Bichim Biphys Acta. 2009;l790(ll):l533-l540. [PubMed]
17. Schomburg L, Kohrle J. On the importance of selenium and 10dine metabolism for thy roidhorm one bsynthesis am human health. Mol Nutr Food Res. 2008;52(ll):l235-l246. [PubMed]
18. Gromadzinska J, Reszka E, Bruzelius K, WasowiczW, Akesson B. Selenium and cancer: bmarkers of selenium sta1 and molecular action of selenium supplements. Eur JNutr. 2008547(2):29-50. [PubMed]
19. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium toselenoproteins: synthesis, identity andtheir role in hum health. AntixidRedox Signal. 2007;9(7):775-8o6. [PubMed]
20. Sanmartin C, Piano D, Font M, Pal op JA. Selenium and clinical trials: new therapeutic evidence for multiple diseat Curr MedChem. 2011;l8(3o):4635- 46so. [PubMed]
21. Kuklinsky B, Schweder R. Acute pancreatitis, a free radical disease; reducing lethality with the sodium selenite an other antixidants. JNutr Environ Med. 1996;6:393-394.
22. Hasselmark L, Malmgren R, Zetterstrom O, Unge G. Selenium supplementation in intrinsic asthma. Allergy. !993;48(l):3O-36. [PubMed]
23. Angstwurm MWA, Schottdorf J, Schopohl J, Gartner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999;27(9):l8o7-l8l3. [PubMed]
24. Peretz A, Siderova V, Neve J. Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-contredtrial. Scand JRheumatol. 2001;30(4):208-2l2. [PubMed]
25. Stone CA, Kawai K, Kupka R, Fawzi WW. Role of selenium in HIV infection. Nutr Rev. 2010;68(ll):67l-68l. [PMCfree article] [PubMed]
26. Kato MA, Finley DJ, Lubitz CC, Zhu B, MooTA, 10even MR, Ricci JA, Zarnegar R, Katdare M, Fahey TJ., 3rd Selenium decreases thyroid cancer cell growth by increasing expressn of GADD153 andGADD34. Nutr Cancer. 2010;62(l):66-73. [PubMed]
27. Lukas J, Drabek J, Lukas D, Dusek L, Gatek J. The epidemgy of thyroid cancer in the Czech Republic in comparison with other countries. Bimed Pap Med FacUniv Palacky O10mouc Czech Repub. 20135157(3):266-275. [PubMed]
28. GlattreE, Nygard JF, Aaseth J. Selenium and cancer prevention: observations and complexity. J Trace El em Med Bid. 2012;26(2-3):l68-l69. [PubMed]
29. Jonklaas J, Daniel sen M, Wang H. A pit study of serum selenium, vitamin D, and TSH concentrations in patients with thyroid cancer. Thyroid. 2013;23(9):1079-1086. [PMCfree article] [PubMed]
30. Mittag J, Behrends T, Hoefig CS, Vennstrom B, Schomburg L. Thyroid hormones regulateselenoprotein expressn and selenium status in mice. P S One. 2010;5(9):el293l. [PMCfree article] [PubMed]
31. Gillespie EF, Smith TJ, Douglas RS. Thyroid eye disease: towards an evidence base for treatment in the 21st century. Curr Neurol Neurosci Rep. 2012;l2(3):3l8-324. [PMCfree article] [PubMed]
32. Mehdi Y, Hornick JL, IstasseL, Dufrasne I. Selenium in the environment, metabolism and involvement in body functions. Molecules. 2013;l8(3):3292-33ll. [PubMed]
33. Thavarajah D, Thavarajah P, Wejesuriya A, Rutzke M, Glahn RP, Combs GF, Jr., Vandenberg A. The potential of lentil (Lens culinarisL.)asa whole food for increased selenium, iron, and zinc intake: preliminary results from a 3 year study. Euphytica. 2011;l8o(l):l23-l28.
34. Das S, Bhansali A, Dutta P, Aggarwal A, Bansal MP, Garg D, Ravikiran M, Walia R, Upreti V, Ramakrishnan S, Sachdeva N, Bhadada SK. Persistence of goitre in thepost-10dization phase: micron utrient deficiency or thyroid autoimmunity? Indian J Med Res. 2011;l33:103-109. [PMCfree article] [PubMed]
35. Ay din K, Kendirci M, Kurtoglu S, Karakiiciik El, Kiris, A. 10dine and selenium deficiency in school children in an endemic goitre area in Turkey. J Pediatr Endocrinol Metab. 2002;l5(7):1027-103l. [PubMed]
36. Xia Y, Hill KE, Byrne DW, Xu J, Burk RF. Effectiveness of selenium supplements in a 10w-selenium area of China. Am JClin Nutr. l998;8l(4):829-834. [PubMed]
37. Keshteli AH, Hashemipour M, Siavash M, Amini M. Selenium deficiency as a possible contributor of goiter in schoolchildren of Isfahan, Iran. Bil Trace Elem Res. 2009;l29(l-3):7O-77. [PubMed]
38. Hira CK, Partal K, Dhiln KS. Dietary selenium intake by men and women in high and 10w selenium areas of Punjab. Public Health Nutr. 2004;7(l):39-43. [PubMed]
39. Fairweather-TaitSJ, BaoY, Broadley MR, C011ings R, FordD, Hesketh JE, Hurst R. Selenium in human health and disease. AntixidRedox Signal. 2011;l4(7):l337-l383. [PubMed]
40. Tan J, Zhu W, Wang W, Li R, Hou S, Wang D, Yang L. Selenium in soil and endemic diseases in China. 2002. Sci Total Environ. 2002;284(l-3):227-235. [PubMed]
41. Parr RM, Crawley H, Abdulla M, Iyengar GV, Kumpulainen J. Report NAHRES-12. Vienna: IAEA; 1992. Human dietary intakes of trace elements: A gbal literature survey mainly for the per10d 1970-1991:1. Data listings and sources of information.
42. Navarro-Alarcon M, Cabrera-ViqueC. Selenium in food and the human body: a review. Sci Total Environ. 20085400(1-3):ll5-l4l. [PubMed]
43. Dumont E, Vanhaecke F, Corn el is R. Selenium speciation from food source to metabolites: a critical review. Anal Bianal Chem. 2006;38s(7):l3O4-l323. [PubMed]
44. 44-Whanger PD. Selenium andits relationship tocancer: An update. Br JNutr. 2004;9l(l):ll-28. [PubMed]
45. Reyes LH, Mar JL, Rahman GM, Seybert B, FahrenholzT, Kingston HM. Simultaneous determination of arsenic and selenium species in fish tissues using microwave assisted enzymatic extraction and n chromatography inductively coupled plasma mass spectrometry. Talanta. 2009;78(3):983-990. [PubMed]
46. Ray man MP, Infante HG, Sargent M. Food-chain selenium andhuman health: spotlight on speciation. Br JNutr. 2008;10o(2):238-253. [PubMed]
47. Fairweather-Tait SJ, C011ings R, Hurst R. Selenium b10availability: current knowledge and future research requirements. Am JClin Nutr. 2010;9l(5):l484S-l49lS. [PubMed]
48. Kohrle J, Brigelius-Fhe R, Bock A, Gartner R, Meyer O, FheL. Selenium in bgy: facts and medical perspectives. Bil Chem. 20005381:849-864. [PubMed]
49. Fhe L, Aumann K-D, Stein ert P. Role of selenium in the enzymatic reduction of hydroperoxides. Phosphorous Sulfur Silicon. l998;l36-l38:25-42.
50. Duntas LH. Environmental factors and thyroid autoimmunity. Ann Endocrinol (Paris) 2011572(2) :108-113. [PubMed]
51. Gartner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. JClin Endocrinol Metab. 2002;87(4):l687-l69l. [PubMed]
52. Tayr EW. Selenium and cellular immunity. Evidence that selenoproteins may be encoded in the +1 reading frame overlapping the human CD4, CD8, and HLA-DR genes. Bil Trace Elem Res. l995;49(2-3):85-95. [PubMed]
53. Cheng W, Fu YX, Porres JM, Ross DA, Lei XG. Selenium-dependent cellular glutathne peroxidase protects mice against a pro-oxidant-induced oxidation of NADPH, NADH, lipids, and protein. FASEB J. 1999513(ll):l467-1475. [PubMed]
54. Hill KE, Burk RF. Selenoprotein P: recent studies in rats and in humans. Bimed Environ Sci. 1997;10:l98-208. [PubMed]
55. Mostert V. Selenoprotein P: properties, functions, and regulation. Arch Bichem Biphys. 20005376(2):433-438. [PubMed]
56. Burk RF, Hill KE. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr. 2005525:215-35. [PubMed]
57. Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF. Selenoprotein P concentration in plasma is an index of selenium status in selenium deficient and selenium supplemented Chinese subjects. J Nutr. 1996;l26(l):l38-145. [PubMed]
58. Zagrodzki P, Ratajczak R. Selenium supplementation in autoimmune thyroiditis female patient-effects on thyroid andovarian functions (casestudy) Bil Trace Elem Res. 2008;l26(l-3):76-82. [PubMed]
59. Zagrodzki P, Ratajczak R. Selenium status, sex hormones, and thyroid function in young women. J Trace Elem Med Bil. 2008;22(4):296-304. [PubMed]
60. Triggiani V, TafaroE, Giagulli VA, Sabba C, Resta F, Licchelli B, Guastamacchia E. Role of 10dine, selenium and other micronutrients in thyroid function and disorders. Endocr Metab Immune Disord Drug Targets. 200959(3)-277-294. [PubMed]
61. Hammouda F, Messaoudi I, El Hani J, Baati T, Said K, Kerkeni A. Reversal of cadmium-inducedthyroiddysfunction by selenium, zinc, or their combination in rat. Bil Trace Elem Res. 2008;l26(l-3):l94-203. [PubMed]
62. Hess SY. The impact of common micronutrient deficiencies on 10dine and thyroid metabolism: the evidence from human studies. Best Pract Res Clin Endocrinol Metab. 20l0;24(l):ll7-l32. [PubMed]
63. Kazi TG, KandhroGA, Sirajuddin, Afridi HI, Baig JA, Shah AQ, Wadhwa SK, Khan S, Kolachi NF, Shaikh HU. Evaluation of 10dine, iron, andselenium in bgical samples of thyroi dm other andtheir newly born babies. Early Hum Dev. 2010;86(10):649-655. [PubMed]
64. Corvilain B, van Sande J, Laurent E, Dumont JE. The H202-generating system modulates protein 10dination and the activity of the pentose phosphate pathway indog thyroid. Endocrinogy. l99l;l28(2):779-785. [PubMed]
65. Corvilain B, Laurent E, Lecomte M,Vansande J, Dumont JE. Role of the cyclic adenosine3',5'-monophosphateandthe phosphatidylinositol-Ca2+cascades in mediating the effects of thyrotropin and 10dide on hormone synthesis and secretion in human thyroid slices. JClin Endocrinol Metab. 1994;79(l):l52-159. [PubMed]
66. Kohrle J, Jakob F, Conternpre B, Dumont J E. Selenium, the thyroid, and the endocrine system. Endocrine Reviews. 44-984. [PubMed]
67. Farber JL, Kyle ME, Col em an JB. Mechanisms of cell injury by activated oxygen species. Lab Invest. 1990562(6) 1670-679. [PubMed]
68. Stazi AV, Trinti B. Selenium status and over-expressn of interleukin-15 in celiac disease and autoimmune thyroid diseases. Ann 1st Super Sanita. 2010;46(4):389-99. [PubMed]
69. Petricca D, Nacamulli D, Mian C, ManteroF, Cavedon E, Girelli ME, BetterleC. Effects of selenium supplementation on the natural course of autoimmune thyroi ditis: a short review. J Endocrinol Invest. 2012535 (4) 1419-424. [PubMed]
70. Balazs C, Kaczur V. Effect of selenium on HLA-DR expressn of thy rocytes. Autoimmune Dis. 2012:374635. [PMCfree article] [PubMed]
71. MorshedSA, Latif R, Da vies TF. Delineating the autoimmune mechanisms in Graves'disease. Immunol Res. 2012;54(l-3):l9l-203. [PubMed]
72. Pedersen IB, Knudsen N, Carle A, Schomburg L, Kohrle J, Jorgensen T, Rasmussen LB, Ovesen L, Laurberg P. Serum selenium is 10w in newly diagnosed Graves'disease: a population-basedstudy. Clin Endocrinol (Qxf) 2013;79(4):584-590. [PubMed]
73. Xu J, Liu XL, Yang XF, GuoHL, ZhaoLN, Sun XF. Supplemental selenium alleviates the toxic effects of excessive 10dine on thyroid. Bil Trace El em Res. 2011;l4l(l-3):ll0-ll8. [PubMed]
74. Bhuyan AK, Sarma D, Saikia UK. Selenium and the thyroid: A cse-knit connection. Indian J Endocrinol Metab. 2012;l6(Suppl 2):S354-5. [PMCfree article] [PubMed]
75. Con tern pre B, Denef JF, Dumont JE, Many MC. 1993 Selenium deficiency aggravates the necrotizing effects of a high 10dide dose in 10dine deficient rats. Endocrinogy. 1993;l32(4):l866-l868. [PubMed]
76. Con tern pre B, Le-MoineO, Dumont JE, Denef JF, Many MC. 1996 Selenium deficiency and thyroid fibrosis. A key role for macrophages andtransforming growth factor p (TGF-p) Mol Cell Endocrinol. 1996;124(i-2):7-15. [PubMed]
77. Rasmussen LB, Schomburg L, Kohrle J, Pedersen IB, Henbach B, Hog A, Ovesen L, PerrildH, Laurberg P. Selenium status, thyroid volume, andmultiple nodule formation in an area with mild 10dine deficiency. Eur J Endocrinol. 85-90. [PubMed]
78. Doupis J, Stavrianos C, Sal tiki K, Mantzou E, Mastrokostopous A, Philippou G, Alevizaki M. Thyroid volume, selenium levels and nutritional habits in a rural regn in Albania. Hormones (Athens) 2009;8(4):296-3O2. [PubMed]
79. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am. 2001;3o(2):3l5-337. [PubMed]
80. Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am. 200029(2):339-355. [PubMed]
81. Swain M, Swain T, Mohanty BK. Autoimmunethyroiddisorders-An update. Indian JClin Bichem. 2005;2o(l):9-l7. [PMCfree article] [PubMed]
82. Krogge SJ, Frauman AG. Expressn of TSH-R in normal human extraocular muscles. Br JOphthalmol. 2006;9o(l):l24-l25. [PMCfree article] [PubMed]
83. Boschi A, DaumerieCh, Spiritus M, Beguin C, Senou M, Yuksel D, Duplicy M, Costagl10la S, Ludgate M, Many MC. Quantification of cells expressing the thy rotropin receptor in extraocular muscles in thyroid associated orbitopathy. Br J Ophthalmol. 2005;89(6):724-729. [PMCfree article] [PubMed]
84. Khalilzadeh O, Nosh ad S, Rashidi A, Amirzargar A. Graves'ophthalmopathy: a review of immunogenetics. Curr Genomics. 2011;l2(8):564-575. [PMCfreearticle] [PubMed]
85. PerriconeC, DeCarolis C, Perricone R. Glutathne: a key player in autoimmunity. Autoimmun Rev. 2009;8(8):697-701. [PubMed]
86. Chardes T, Chapal N, Bresson D, Bes C, Giudicelli V, Lefranc MP, Peraldi-Roux S. The human anti-thyroid peroxidase autoantibody repertoirein Graves'and Hashimoto's autoimmunethyroiddiseases. Immunogenetics. 2002;54(3):l4l-l57. [PubMed]
87. Zagrodzki P, Przybylik-Mazurek E. Selenium and hormone interactions in female patients with Hashimotodisease and healthy subjects. Endocr Res. 2010;35(l):24-34. [PubMed]
88. Gartner R, Duntas LH. Effects of selenium supplementation on TPOAb andcytokines in acute autoimmune thy roiditis Thyroid. 2008;l8(6):669-67O; author reply 673-674. [PubMed]
89. KaranikasG, SchuetzM, KonturS, Duan H, Kommata S, Schoen R, Antoni A, Kletter K, Dudczak R, Willheim M. No immunogical benefit of selenium in consecutive patients with autoimmune thy roiditis. Thyroid. 2008;l8(l):7-l2. [PubMed]
90. Toulis KA, Anastasilakis AD, Tzels TG, Goulis DG, Kouvelas D. Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-Analysis. Thyroid. 2010;2o(10):ll63-ll73. [PubMed]
91. Balazs C, FeherJ. The effect of selenium therapy on autoimmune thy roiditis. Clin Experimenta Med J. 200953 (2) 1269-277.
92. Anastasilakis AD, Toulis KA, Nisianakis P, Goulis DG, Kampas L, Valeri RM, Oikonomou D, Tzels TG, Delaroudis S. Selenomethnine treatment in patients with autoimmune thy roiditis: a prospective, quasi-randomised trial. Int JClin Pract. 2012;66(4):378-383. [PubMed]
93. Bonfig W, Gartner R, Schmidt H. Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. Scientific World Journal. 2010510:990-996. [PubMed]
94. Ademoglu E, Ozbey N, Erbil Y,Tanrikulu S, Barbaros U, Yanik BT, Bozbora A, Ozarmagan S. Determination of oxidative stress in thyroid tissue and pi asm a of patients with Graves'disease. Eur Jin tern Med. 2006517(8) :54s-550. [PubMed]
95. NegroR. Selenium andthyroidautoimmunity. Bigies. 2008;2(2):265-273. [PMCfreearticle] [PubMed]
96. Weetman AP. Graves'disease. NewEngl J Med. 20005343:1236-48. [PubMed]
97. Wertenbruch T, Willenberg HS, Sagert C, Nguyen TB, Bah10M, Feldkamp J, Groeger C, Hermsen D, Scherbaum WA, Schott M. Serum selenium levels in patients with remissn and relapse of Graves'disease. MedChem. 200753:281-284. [PubMed]
98. Duntas LH. Selenium andthethyroid: a cse-knit connection. JClin Endocrinol Metab. 2010;95(l2):5l8o-5l88. [PubMed]
99. 99-Vrca VB, Skreb F, Cepelak I, Mayer L. Supplementation with antixidants in the treatment of Graves'disease: the effect on the extracellular antixidative parameters. Acta Pharm. 2004;54(2):79-89. [PubMed]
100. TolandoR, Jovanovic A, Brigelius-Fhe R, Ursini F, Ma rinoM. Reactive oxygen species andproinflammatory cytokine signaling in endothelial cells: effects of selenium supplementation. Free Radic Bil Med. 200028(6):979-986. [PubMed]
101. Forman HJ, Torres M. Reactive oxygen species and cell signalling: respiratory burst in macrophage signaling. Am J Resp Crit Care Med. 2002;l66(l2 Pt 2):S4-S8. [PubMed]
102. Xue H, WangW, Li Y, Shan Z, Li Y,TengX, GaoY, Fan C, TengW. Selenium upregulates CD4(+) CD25(+) regulatory T cells in 10dine-induced autoimmune thy roiditis model of NOD. H-2(h4) mice. En doer J. 2010557(73:5 95-601. [PubMed]
103. Schweizer U, Dehina N, Schomburg L. Disorders of selenium metabolism andselenoprotein function. Curr Opin Pediatr. 2011;23(4):429-435. [PubMed]
104. Schomburg L, Dumitrescu AM, LiaoXH, Bin-Abbas B, Hoeflich J, Kohrle J, Refetoff S. Selenium supplementation fails to correct theselenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid. 2009519(3) '-2.JJ-281. [PMCfree article] [PubMed]
105. Gartner R. Selenium and thyroid hormone axis in critical ill states: an overview of conflicting view points. J Trace El em Med Bil. 2009;23(2):7l-74. [PubMed]
106. Tiran B, Tiran A, Rossipal E, renz O. Simple decomposition procedure for determination of selenium in whole b10od, serum and urine by hydridegeneration atomic absorption spectroscopy. JTrace El em Electrolytes Health Dis. 1993;7(4):2ll-2l6. [PubMed]
107. Thomson CD, McLachlan SK, Grant AM, Paterson E, LillicoAJ. The effect of selenium on thyroid status in a population with marginal selenium and 10dine status. Br JNutr. 2005594(6):962-968. [PubMed]
108. Jacobson BE, 10ckitch G. Direct determination of selenium in serum by graphite-furnace atomic absorption spectrometry with deuterium background correction anda reduced palladium modifier: age-specific reference ranges. Clin Chem. 1988;34(4):7O9-714. [PubMed]
109. Paglia DE, ValentineWN. Studies on the quantitative and qualitative characterization of erythrocyteglutathne peroxidase. J Lab Clin Med. 1967;7o(l):l58-l69. [PubMed]
110. Thomson CD, Robinson MF, Campbell DR, Rea HM. Effect of prongedsupplementation with daily supplements of selenomethnine and sodium selenite onglutathneperoxidise activity in b10od of New Zealand residents. Am J Clin Nutr. 1982;36(l):24-3l. [PubMed]
111. Rayman MP. Selenium and human health. Lancet. 2012;379(9822):l256-l268. [PubMed]
112. Schrauzer GN, White DA. Selenium in human nutrition: dietary intakes and effects of supplementation. Biinorg Chem. l978;8(4):3O3-3l8. [PubMed]
113. Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur JEndocrinol. 2004;l50(5):6O5-6l8. [PubMed]
114. Patterson P, Levander OA. Naturally occurring selenium compounds in cancer chemoprevention trials: a workshop summary. Cancer Epideml Bimarkers Prev. 1997;6(l):63-69. [PubMed]
115. McCann JC, Ames BN. Adaptive dysfunction of selenoproteins from the perspective of the triage theory: why modest selenium deficiency may increase risk of diseases of aging. FASEB J. 2011;25(6):l793-l8l4. [PubMed]
116. Weitzel F, Ursini F, Wendel A. Phospholipid hydroperoxide glutathne peroxidase in varus mouse organs during selenium deficiency and repletion. Bichim Biphys Acta. l990;1036(2):88-94. [PubMed]
117. 117-BermanoG, Nicol F, Dyer JA, SundeRA, Beckett GJ, Arthur JR, Hesketh JE. Selenoprotein gene expressn during selenium-repletion of selenium-deficient rats. Bil Trace El em Res. l996;5l(3):2ll-223. [PubMed]
118. Thomson CD, Campbell JM, Miller J, Skeaff SA. Minimal impact of excess 10date intake on thyroid hormones and selenium status in older NewZealanders. Eur JEndocrinol. 20115165(5):74s-752. [PubMed]
119. Thomson CD, Campbell JM, Miller J, Skeaff SA, Livingstone V. Selenium and 10dine supplementation: effect on thyroid function of older NewZealanders. Am JClin Nutr. 2009;9o(4):1038-1046. [PubMed]
120. Combs GF, Jr., Midthune DN, Patterson KY, CanfieldWK, Hill AD, Levander OA, Tayr PR, Moler JE, Patterson BH. Effects of selenomethnine supplementation on selenium status andthyroid hormone concentrations in healthy adults. Am JClin Nutr. 2009;89(6):l8o8-l8l4. [PMCfree article] [PubMed]
121. Rayman MP, Thompson A J, Bekaert B, Catterick J, Galassini R, Hall E, Warren-Perry M, Beckett GJ. Randomized contred trial of the effect of selenium supplementation onthyroid function in the elderly in the United Kingdom. Am J Clin Nutr. 2008;87(2):37O-178. [PubMed]
122. Ravaglia G, Forti P, Ma li F, Nesi B, Pratelli L, SavarinoL, Cucinotta D, Cavalli G. Biod micron utri en t andthyroid hormone concentrations in the oldest-old. J Clin Endocrinol Metab. 200085(6):226o-2565. [PubMed]
123. Du f fi eld A J, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for NewZealanders. Am J Clin Nutr. l999;7O(s):896-903. [PubMed]
124. Olivieri O, Girelli D, Azzini M, Stanzial AM, RussoC, Ferroni M, Corrocher R. 10w selenium status in the elderly influences thyroid hormones. Clin Sci (nd) l995;89(6):637-642. [PubMed]
125. Nacamulli D, Mian C, Petricca D, LazzarottoF, Bar011oS, Pozza D, MasieroS, Faggian D, Plebani M, Girelli ME, ManteroF, BetterleC. Influence of physgical dietary elenium upplementation on the natural course of autoimmune thyroiditis. Clin Endocrinol (Oxf) 2010;73(4):535-539. [PubMed]
126. Onal H, Keskindemirci G, Adal E, Ersen A, KorkmazO. Effects of selenium supplementation in the early stage of autoimmune thyroiditis in childhood: an open-label pit study. JPediatr Endocrinol Metab. 2012;25(7-8):639-644. [PubMed]
127. Marcocci C, Altea MA, LeoM. Treatment options for Graves'orbitopathy. Expert Opin Pharmacother. 2012513(6):79s-806. [PubMed]
128. Nuttall KL. Evaluating selenium poisoning. Ann Clin Lab Sci. 2006;36(4):409-420. [PubMed]
129. 10ckitch G. Selenium: clinical significance and analytical concepts. Crit Rev Clin Lab Sci. 1989527(6):483-541. [PubMed]
130. Yang GQ, Wang SZ, Zhou RH, Sun SZ. Endemic selenium intoxication of humans in China. Am JClin Nutr. l983;37(5):872-88l. [PubMed]
131. Paul M, Mason R, Edwards R. Effect of potential antidotes on the acute toxicity, tissue disposition and elimination of selenium in rats. Res Commun Chem Pathol Pharmacol. 1989;66(3):44l-450. [PubMed]
132. Duntas LH. Environmental factors andautoimmunethyroiditis. Nat Clin Pract Endocrinol Metab. 2008;4(8):454-40. [PubMed]
133. Dickson RC, Tomlinson RH. Selenium in b10od and human tissues. Clin Chim Acta. 1967;l6(2):3ll-32l. [PubMed]
134. Drutel A, Archambeaud F, Caron P. Selenium andthethyroidgland: more good news for clinicians. Clin Endocrinol (Oxf) 2013;78(2):l55-l64. [PubMed]
135. Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W, European Group on Graves'Orbitopathy Selenium and the course of mild Graves' orbitopathy. N Engl JMed. 20115364(20) 11920-1931. [PubMed]